Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

MedTech Dive February 27, 2025
Susan Kelly

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

Dive Brief:

• Teleflex will split into two publicly traded companies, with the new entity comprising its urology, acute care and OEM businesses. The remaining company will consist of the hospital-focused vascular access, interventional and surgical businesses.
• The separation positions each organization to accelerate growth under a simplified operating model and increased management focus, with a streamlined manufacturing footprint and better allocation of resources, Teleflex said in a Thursday announcement.
• In addition, Teleflex said it agreed to pay about 760 million euros (about $791 million) to acquire nearly all of Biotronik’s vascular intervention division. The company also announced the...

Today's Sponsors

Today's Sponsor